CARDIOTOXICITY
Clinical trials for CARDIOTOXICITY explained in plain language.
Never miss a new study
Get alerted when new CARDIOTOXICITY trials appear
Sign up with your email to follow new studies for CARDIOTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Exercise may shield breast cancer Survivors' hearts from chemo damage
Disease control Not yet recruitingThis study tests whether a 16-week supervised exercise program can help prevent heart damage in breast cancer survivors. Many breast cancer treatments can harm the heart, and this trial aims to see if regular exercise can protect it. The study will include 44 women who finished c…
Matched conditions: CARDIOTOXICITY
Phase: NA • Sponsor: University of Castilla-La Mancha • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
AI heart scan could spare cancer patients costly MRI scans
Diagnosis Not yet recruitingThis study compares a new AI-enhanced 3D ultrasound system to standard ultrasound and MRI for detecting heart damage in 120 adults who have received chemotherapy. The goal is to see if the AI method can accurately measure heart function faster and more affordably than current app…
Matched conditions: CARDIOTOXICITY
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Diagnosis
Last updated May 22, 2026 14:05 UTC
-
New trial aims to shield cancer Patients' hearts from chemo side effects
Prevention Not yet recruitingThis study tests whether the drug sotagliflozin can prevent heart, muscle, and fat damage caused by a common type of chemotherapy (anthracycline) in people with newly diagnosed lymphoma. About 60 participants will receive either the drug or a placebo during their first round of c…
Matched conditions: CARDIOTOXICITY
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Prevention
Last updated May 26, 2026 03:09 UTC
-
New study aims to predict heart risks in stem cell recipients
Knowledge-focused Not yet recruitingThis study will follow 400 people receiving a stem cell transplant for blood cancers to learn why some develop serious heart problems like heart attacks, irregular heartbeat, or heart failure. Researchers will use heart scans, EKGs, and blood tests to find early warning signs. Th…
Matched conditions: CARDIOTOXICITY
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 26, 2026 03:16 UTC
-
New tool aims to shield cancer Survivors' hearts
Knowledge-focused Not yet recruitingThis study tests a new tool that helps doctors and cancer survivors decide together on the best heart-protecting medications and heart scans. About 60 adult cancer survivors who have not yet seen a heart specialist will take part. The goal is to see if the tool is easy to use and…
Matched conditions: CARDIOTOXICITY
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 26, 2026 03:06 UTC
-
New study tracks hidden heart risks in breast cancer treatment
Knowledge-focused Not yet recruitingThis study follows 100 women with early-stage breast cancer who are receiving standard chemotherapy or anti-HER2 therapy. Researchers want to see if special heart ultrasound scans or blood tests can detect early heart damage before standard tests show a problem. Participants will…
Matched conditions: CARDIOTOXICITY
Sponsor: Fatih GURLER • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC